Abstract
Background
Young atrial fibrillation (AF) patients have been underrepresented in studies of radiofrequency catheter ablation (RFCA) and the outcome of RFCA has not been widely addressed. We investigated age-related differences in clinical features, the recurrence of atrial tachyarrhythmia, and its predictors of patients who underwent RFCA for AF.
Methods
This is a multicenter prospective study of 2799 patients who underwent RFCA for AF in 2017–2020. The patients were divided into two groups — group A (age < 60 years, n = 1269) and group B (age ≥ 60 years, n = 1530) — and a recurrence of any atrial tachyarrhythmia 1 year after RFCA following a 90-day blanking period was compared.
Results
The mean age was 51.6 ± 6.7 and 66.8 ± 5.2 years for groups A and B, respectively. Higher body mass index, smaller left atrium, and more prevalent cardiomyopathy and obstructive sleep apnea were observed in group A. Overall, 1-year atrial tachyarrhythmia-free survival was 85.6% and lower in young patients (83.1% in group A vs. 87.7% in group B, log-rank p < 0.01): adjusted hazard ratio (aHR) of recurrence (95% confidence interval (CI)), 1.45 (1.13–1.86) for group A compared to group B (p < 0.01). The association between younger age and higher recurrence was continuously observed in patients under 60 years. Any non-PV ablation was associated with a lower recurrence of atrial tachyarrhythmia in group B (aHR 0.68 (0.47–0.96), p < 0.05), but not in group A.
Conclusions
AF patients younger than 60 years had a higher 1-year AF recurrence after RFCA. Young AF patients might have distinctive pathophysiology of AF requiring more integrated management.
Similar content being viewed by others
Data Availability
All data generated or analyzed during this study are included in this published article and its supplementary information files.
References
Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstrom-Lundqvist C, Boriani G, Castella M, Dan GA, Dilaveris PE, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373–498.
Staerk L, Sherer JA, Ko D, Benjamin EJ, Helm RH. Atrial Fibrillation: Epidemiology, Pathophysiology, and Clinical Outcomes. Circ Res. 2017;120(9):1501–17.
Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, Gillum RF, Kim YH, McAnulty JH Jr, Zheng ZJ, et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014;129(8):837–47.
Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285(18):2370–5.
Wasmer K, Breithardt G, Eckardt L. The young patient with asymptomatic atrial fibrillation: what is the evidence to leave the arrhythmia untreated? Eur Heart J. 2014;35(22):1439–47.
Vermond RA, Geelhoed B, Verweij N, Tieleman RG, Van der Harst P, Hillege HL, Van Gilst WH, Van Gelder IC, Rienstra M. Incidence of Atrial Fibrillation and Relationship With Cardiovascular Events, Heart Failure, and Mortality: A Community-Based Study From the Netherlands. J Am Coll Cardiol. 2015;66(9):1000–7.
Nattel S, Guasch E, Savelieva I, Cosio FG, Valverde I, Halperin JL, Conroy JM, Al-Khatib SM, Hess PL, Kirchhof P, et al. Early management of atrial fibrillation to prevent cardiovascular complications. Eur Heart J. 2014;35(22):1448–56.
Mestroni L. Genomic medicine and atrial fibrillation. J Am Coll Cardiol. 2003;41(12):2193–6.
Camm AJ, Naccarelli GV, Mittal S, Crijns H, Hohnloser SH, Ma CS, Natale A, Turakhia MP, Kirchhof P. The Increasing Role of Rhythm Control in Patients With Atrial Fibrillation: JACC State-of-the-Art Review. J Am Coll Cardiol. 2022;79(19):1932–48.
Buist TJ, Zipes DP, Elvan A. Atrial fibrillation ablation strategies and technologies: past, present, and future. Clin Res Cardiol. 2021;110(6):775–88.
Santangeli P, Marchlinski FE. Techniques for the provocation, localization, and ablation of non-pulmonary vein triggers for atrial fibrillation. Heart Rhythm. 2017;14(7):1087–96.
Sultan A, Luker J, Andresen D, Kuck KH, Hoffmann E, Brachmann J, Hochadel M, Willems S, Eckardt L, Lewalter T, et al. Predictors of Atrial Fibrillation Recurrence after Catheter Ablation: Data from the German Ablation Registry. Sci Rep. 2017;7(1):16678.
Darby AE. Recurrent Atrial Fibrillation After Catheter Ablation: Considerations For Repeat Ablation And Strategies To Optimize Success. J Atr Fibrillation. 2016;9(1):1427.
Balk EM, Garlitski AC, Alsheikh-Ali AA, Terasawa T, Chung M, Ip S. Predictors of atrial fibrillation recurrence after radiofrequency catheter ablation: a systematic review. J Cardiovasc Electrophysiol. 2010;21(11):1208–16.
Dretzke J, Chuchu N, Agarwal R, Herd C, Chua W, Fabritz L, Bayliss S, Kotecha D, Deeks JJ, Kirchhof P, et al. Predicting recurrent atrial fibrillation after catheter ablation: a systematic review of prognostic models. Europace. 2020;22(5):748–60.
Ghannam M, Chugh A, Bradley DJ, Crawford T, Latchamsetty R, Ghanbari H, Cunnane R, Saeed M, Jongnarangsin K, Pelosi F, Jr. et al. Clinical characteristics and long-term outcomes of catheter ablation in young adults with atrial fibrillation. J Interv Card Electrophysiol. 2022;64(2):311-319.
Asad ZUA, Yousif A, Khan MS, Al-Khatib SM, Stavrakis S. Catheter Ablation Versus Medical Therapy for Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Circ Arrhythm Electrophysiol. 2019;12(9):e007414.
Allam L, Samir R, Ali AN. Clinical outcomes of catheter ablation of paroxysmal atrial fibrillation in very young population compared to older population: a prospective study. Egypt Heart J. 2019;71(1):11.
Dewire J, Agarwal S, Khurram IK, Marine JE, Berger R, Spragg D, Ashikaga H, Rickard J, Nazarian S, Calkins H. Safety and Efficacy of Atrial Fibrillation Ablation in Young Patients. J Atr Fibrillation. 2013;6(3):915.
Chun KR, Schmidt B, Kuck KH, Andresen D, Willems S, Spitzer SG, Hoffmann E, Schumacher B, Eckardt L, Seidl K, et al. Catheter ablation of atrial fibrillation in the young: insights from the German Ablation Registry. Clin Res Cardiol. 2013;102(6):459–68.
Saguner AM, Maurer T, Wissner E, Santoro F, Lemes C, Mathew S, Sohns C, Heeger CH, Reissmann B, Riedl J, et al. Catheter ablation of atrial fibrillation in very young adults: a 5-year follow-up study. Europace. 2018;20(1):58–64.
Leong-Sit P, Zado E, Callans DJ, Garcia F, Lin D, Dixit S, Bala R, Riley MP, Hutchinson MD, Cooper J, et al. Efficacy and risk of atrial fibrillation ablation before 45 years of age. Circ Arrhythm Electrophysiol. 2010;3(5):452–7.
Lee E, Park H-S, Han S, Nam G-B, Choi J-I, Pak H-N, Oh I-Y, Shin D-G, On YK, Park SW, et al. Catheter ablation of atrial fibrillation in Korea: results from the Korean Heart Rhythm Society Ablation Registry for Atrial Fibrillation (KARA). Int J Arrhythmia. 2021;22(1):20.
Alzahrani Z, Ornelas-Loredo A, Darbar SD, Farooqui A, Mol D, Chalazan B, Villagrana NE, McCauley M, Lazar S, Wissner E, et al. Association Between Family History and Early-Onset Atrial Fibrillation Across Racial and Ethnic Groups. JAMA Netw Open. 2018;1(5): e182497.
Lee JY, Kim TH, Yang PS, Lim HE, Choi EK, Shim J, Shin E, Uhm JS, Kim JS, Joung B, et al. Korean atrial fibrillation network genome-wide association study for early-onset atrial fibrillation identifies novel susceptibility loci. Eur Heart J. 2017;38(34):2586–94.
Jahangir A, Lee V, Friedman PA, Trusty JM, Hodge DO, Kopecky SL, Packer DL, Hammill SC, Shen WK, Gersh BJ. Long-term progression and outcomes with aging in patients with lone atrial fibrillation: a 30-year follow-up study. Circulation. 2007;115(24):3050–6.
Nanthakumar K, Lau YR, Plumb VJ, Epstein AE, Kay GN. Electrophysiological findings in adolescents with atrial fibrillation who have structurally normal hearts. Circulation. 2004;110(2):117–23.
Tuan TC, Chang SL, Tsao HM, Tai CT, Lin YJ, Hu YF, Lo LW, Udyavar AR, Chang CJ, Tsai WC, et al. The impact of age on the electroanatomical characteristics and outcome of catheter ablation in patients with atrial fibrillation. J Cardiovasc Electrophysiol. 2010;21(9):966–72.
Kistler PM, Sanders P, Fynn SP, Stevenson IH, Spence SJ, Vohra JK, Sparks PB, Kalman JM. Electrophysiologic and electroanatomic changes in the human atrium associated with age. J Am Coll Cardiol. 2004;44(1):109–16.
Kim D, Hwang T, Kim M, Yu HT, Kim TH, Uhm JS, Joung B, Lee MH, Pak HN. Extra-Pulmonary Vein Triggers at de novo and the Repeat Atrial Fibrillation Catheter Ablation. Front Cardiovasc Med. 2021;8:759967.
Choi SH, Weng LC, Roselli C, Lin H, Haggerty CM, Shoemaker MB, Barnard J, Arking DE, Chasman DI, Albert CM, et al. Association Between Titin Loss-of-Function Variants and Early-Onset Atrial Fibrillation. JAMA. 2018;320(22):2354–64.
Wutzler A, von Ulmenstein S, Attanasio P, Huemer M, Parwani AS, Volk K, Blaschke F, Boldt LH, Haverkamp W. Where There’s Smoke, There’s Fire? Significance of Atrial Fibrillation in Young Patients. Clin Cardiol. 2016;39(4):229–33.
Verma A, Wazni OM, Marrouche NF, Martin DO, Kilicaslan F, Minor S, Schweikert RA, Saliba W, Cummings J, Burkhardt JD, et al. Pre-existent left atrial scarring in patients undergoing pulmonary vein antrum isolation: an independent predictor of procedural failure. J Am Coll Cardiol. 2005;45(2):285–92.
Mahnkopf C, Badger TJ, Burgon NS, Daccarett M, Haslam TS, Badger CT, McGann CJ, Akoum N, Kholmovski E, Macleod RS, et al. Evaluation of the left atrial substrate in patients with lone atrial fibrillation using delayed-enhanced MRI: implications for disease progression and response to catheter ablation. Heart Rhythm. 2010;7(10):1475–81.
Muller M, Paul T. Atrial fibrillation in the young without overt heart disease: Follow the current guidelines. Heart Rhythm. 2021;18(11):1823–4.
Andersson C, Vasan RS. Epidemiology of cardiovascular disease in young individuals. Nat Rev Cardiol. 2018;15(4):230–40.
Han M, Lee SR, Choi EK, Choi J, Chung J, Park SH, Lee H, Ahn HJ, Kwon S, Lee SW, et al. Habitual Alcohol Intake and Risk of Atrial Fibrillation in Young Adults in Korea. JAMA Netw Open. 2022;5(9):e2229799.
Bunch TJ, May HT. Atrial fibrillation: a risk factor or risk marker? Eur Heart J. 2016;37(38):2890–2.
Kim D, Yang PS, You SC, Jang E, Yu HT, Kim TH, Pak HN, Lee MH, Lip GYH, Sung JH, et al. Age and Outcomes of Early Rhythm Control in Patients With Atrial Fibrillation: Nationwide Cohort Study. JACC Clin Electrophysiol. 2022;8(5):619–32.
Kirchhof P, Camm AJ, Goette A, Brandes A, Eckardt L, Elvan A, Fetsch T, van Gelder IC, Haase D, Haegeli LM, et al. Early Rhythm-Control Therapy in Patients with Atrial Fibrillation. N Engl J Med. 2020;383(14):1305–16.
El Assaad I, Hammond BH, Kost LD, Worley S, Janson CM, Sherwin ED, Stephenson EA, Johnsrude CL, Niu M, Shetty I, et al. Management and outcomes of atrial fibrillation in 241 healthy children and young adults: Revisiting “lone” atrial fibrillation-A multi-institutional PACES collaborative study. Heart Rhythm. 2021;18(11):1815–22.
Acknowledgements
We would like to thank all KARA investigators: Jinhee Ahn, Min‑Soo Ahn, Yong‑Soo Baek, Myung‑Jin Cha, Tae‑Joon Cha, Eue‑Keun Choi, Hyung‑Oh Choi, Jong‑Il Choi, Kwang Jin Chun, Hye Bin Gwag, Seongwook Han, Youmi Hwang, Dae Woo Hyun, Eun‑Sun Jin, Ki‑Woon Kang, Dae‑Hyeok Kim, Dae‑Kyung Kim, Dongmin Kim, Ji‑Hoon Kim, Jin‑Bae Kim, Minsu Kim, Sung‑Hwan Kim, Yoo Ri Kim, Young‑Hoon Kim, Jum‑Suk Ko, Jae‑Jin Kwak, Euijae Lee, Sanghee Lee, So‑Ryoung Lee, Sung Ho Lee, Young Soo Lee, Gi‑Byung Nam, Jun Namgung, Il‑Young Oh, Seil Oh, Yong‑Seog Oh, Young Keun On, Hui‑Nam Pak, Hwan‑Cheol Park, Hyoung‑Seob Park, Hyung Wook Park, Sang Weon Park, Ye Min Park, Young‑Ah Park, Kyoung‑Suk Rhee, Jaemin Shim, Dong‑Gu Shin, In‑Geol Song, Jung‑Hoon Sung, and Pil‑Sung Yang.
Funding
This nationwide registry study was supported by a grant from the Korean Heart Rhythm Society 2017.
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Ethical approval
The Institutional Review Board of each participating center approved this study.
Informed consent
The written informed consent was obtained from all the participants.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Ahn, H.J., Cha, MJ., Lee, E. et al. The higher recurrence rate after catheter ablation in younger patients with atrial fibrillation suggesting different pathophysiology. J Interv Card Electrophysiol 66, 1609–1619 (2023). https://doi.org/10.1007/s10840-022-01461-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10840-022-01461-0